Laura Sepp-Lorenzino, EVP, Chief Scientific Officer at Intellia Therapeutics, Inc. (NTLA), sold 8,987 shares at $37.21 ($339K) on 2023-01-04, disclosed to the SEC on 2023-01-06.
Open-market sale of $339k NTLA by EVP, Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.21 | 2,508 | $93K | 27.5% |
| 2 | $37.21 | 2,508 | $93K | 27.5% |
| 3 | $38.22 | 1,641 | $63K | 18.5% |
| 4 | $38.22 | 1,641 | $63K | 18.5% |
| 5 | $39.10 | 689 | $27K | 7.9% |
| Total | $37.72 avg | 8,987 |
| $339K |
| 100% |
| Filing → |
| NTLA | SELL | 2024-01-05 | $326K | — | Filing → |
| NTLA | SELL | 2022-03-03 | $129K | — | Filing → |
| NTLA | SELL | 2021-09-01 | $30.0M | — | Filing → |